Alexander S. Chiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander S. Chiu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Megan C. Saucke
Department of Surgery, University of Wisconsin-Madison, Madison, USA
3 shared publications - Susan C. Pitt
University of Michigan
3 shared publications - Catherine B. Jensen
Department of Surgery University of Michigan Medical School Ann Arbor Michigan USA
2 shared publications - Abdullah Adil
University of Michigan, 1259, Department of Otolaryngology-Head and Neck Surgery, Ann Arbor, Michigan, United States;
1 shared publication - Alexandra Helbing
Division of Endocrine Surgery Department of Surgery School of Medicine and Public Health University of Wisconsin Madison Wisconsin USA
1 shared publication - Alexis G. Antunez
University of Michigan, Ann Arbor, MI, USA
1 shared publication
Latest Publications
- 16 June 2025
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-4
Thyroid Cancer-Specific Worry in the United States: A Survey
- 16 June 2025
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-4
Thyroid Cancer-Specific Worry in the United States: A Survey
- 17 September 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (9) , 1181-1185
Surgeon Preference for Maximizing Medical Care Is Associated with Recommending More Extensive Surgery for Low-Risk Thyroid Cancer
Background: While patient-level determinants of total thyroidectomy use have been well described, surgeon-level drivers of more extensive surgery are present and less well described. This survey sought to examine the associations between surgeons’ operative recommendations, their beliefs about cancer, and their attitudes about medical maximizing-minimizing. Methods: A mixed-mode, cross-sectional survey was administered in September 2020 via mail and email to 222 thyroid surgeons identified in the Centers for Medicare & Medicaid Services Provider Utilization and Payment Physician and Other Practitioners dataset. Participants were asked their treatment recommendation for a healthy 45-year-old woman with a solitary 2.0-cm papillary thyroid cancer. Surgeons were assessed with the Brief Worry Scale and a validated, single-item measure of cancer-related worry. The Clinician Maximizer-Minimizer scale was used to assess the extent of medical care that physicians tend to favor with their patients. Participants were categorized into terciles based on their responses to the Maximizer-Minimizer scale. The highest scoring tercile (“Maximizers”) was compared with the two lower terciles by Student’s t -tests, chi-square, ANOVA, and logistic regression. Results: Of the 149 surgeons (response rate 67.1%), 34.9% recommended total thyroidectomy with or without central neck dissection (CND), and 65.1% recommended lobectomy. Overall, the medical Maximizer-Minimizer scale had an average score of 24.6 (SD 6.8). There were no differences between surgeons’ age, race, annual thyroidectomy volume, or practice setting by their Maximizer-Minimizer classification. Participants who recommended total thyroidectomy with or without CND had significantly higher Maximizer-Minimizer scores than those recommending lobectomy (25.9 ± 7.2 vs. 23.8 ± 6.4, p = 0.03). Those classified as maximizers also had more cancer-related worry on both the single-item and Brief Worry Scales ( p = 0.02). On logistic regression controlling for age, sex, race, specialty training, practice setting, and annual thyroidectomy volume, maximizers were still more likely to recommend total thyroidectomy with or without a CND (OR 2.4, [CI 1.01–5.55], p = 0.047). Conclusions: Medical maximizing-minimizing tendencies represent one of potentially many unmeasured surgeon characteristics that may explain persistent patterns of over-diagnosis, over-treatment, and over-screening. Surgeons may benefit from awareness of how their own tendencies influence their surgical recommendations in patients with low-risk thyroid cancer.
- 17 September 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (9) , 1181-1185
Surgeon Preference for Maximizing Medical Care Is Associated with Recommending More Extensive Surgery for Low-Risk Thyroid Cancer
Background: While patient-level determinants of total thyroidectomy use have been well described, surgeon-level drivers of more extensive surgery are present and less well described. This survey sought to examine the associations between surgeons’ operative recommendations, their beliefs about cancer, and their attitudes about medical maximizing-minimizing. Methods: A mixed-mode, cross-sectional survey was administered in September 2020 via mail and email to 222 thyroid surgeons identified in the Centers for Medicare & Medicaid Services Provider Utilization and Payment Physician and Other Practitioners dataset. Participants were asked their treatment recommendation for a healthy 45-year-old woman with a solitary 2.0-cm papillary thyroid cancer. Surgeons were assessed with the Brief Worry Scale and a validated, single-item measure of cancer-related worry. The Clinician Maximizer-Minimizer scale was used to assess the extent of medical care that physicians tend to favor with their patients. Participants were categorized into terciles based on their responses to the Maximizer-Minimizer scale. The highest scoring tercile (“Maximizers”) was compared with the two lower terciles by Student’s t -tests, chi-square, ANOVA, and logistic regression. Results: Of the 149 surgeons (response rate 67.1%), 34.9% recommended total thyroidectomy with or without central neck dissection (CND), and 65.1% recommended lobectomy. Overall, the medical Maximizer-Minimizer scale had an average score of 24.6 (SD 6.8). There were no differences between surgeons’ age, race, annual thyroidectomy volume, or practice setting by their Maximizer-Minimizer classification. Participants who recommended total thyroidectomy with or without CND had significantly higher Maximizer-Minimizer scores than those recommending lobectomy (25.9 ± 7.2 vs. 23.8 ± 6.4, p = 0.03). Those classified as maximizers also had more cancer-related worry on both the single-item and Brief Worry Scales ( p = 0.02). On logistic regression controlling for age, sex, race, specialty training, practice setting, and annual thyroidectomy volume, maximizers were still more likely to recommend total thyroidectomy with or without a CND (OR 2.4, [CI 1.01–5.55], p = 0.047). Conclusions: Medical maximizing-minimizing tendencies represent one of potentially many unmeasured surgeon characteristics that may explain persistent patterns of over-diagnosis, over-treatment, and over-screening. Surgeons may benefit from awareness of how their own tendencies influence their surgical recommendations in patients with low-risk thyroid cancer.
- 1 February 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (2) , 234-242
Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study
Background: This study aimed to measure fear of thyroid cancer in the general United States (U.S.) population and identify factors associated with a high level of thyroid cancer-specific fear that may contribute to overtreatment. Methods: We conducted a cross sectional survey using Prolific Academic®, an online survey platform. The survey was administered in August 2020 to English speaking adults (>17 years) in the U.S. who were registered with Prolific. The target sample was stratified to represent the demographics of the U.S. population. A validated, 8-item breast cancer fear scale was adapted to measure thyroid cancer-specific fear. Multivariate logistic regression identified factors significantly associated with high levels of thyroid cancer-specific fear. Results: Of the 1,136 respondents (94.3% eligibility), 50.4% were female, 74.1% White, and the mean age was 45 years (SD 16 years). Overall, 47.5% of respondents had high levels of thyroid cancer-specific fear. Multivariate regression demonstrated that age <40 years (OR 2.46 vs. 65+ [95%CI 1.60-3.80] ) and female gender (OR 1.48 vs. Male [95%CI 1.13-1.93] ) were associated with high levels of thyroid cancer fear. Believing thyroid cancer (OR 2.71 [95%CI 1.99-3.69] ) and cancer in general are serious (OR 1.53 [95%CI 1.13-2.08] ) were also associated with high levels of thyroid cancer fear. Respondents who overestimated thyroid cancer incidence (OR 1.64 [95%CI 1.25-2.13] ) and believed they had a high chance of developing cancer (OR 1.70 [95%CI 1.19-2.42] ) were also more likely to have high fear of thyroid cancer. Conclusion: Thyroid cancer-specific fear is prevalent in U.S. adults particularly in females and those younger than 40 years. Because disease-specific fear is associated with overtreatment, targeted education about the seriousness, incidence, and risk factors for developing thyroid cancer may decrease public fear and possibly overtreatment related to “scared decision making.”
- 1 February 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (2) , 234-242
Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study
Background: This study aimed to measure fear of thyroid cancer in the general United States (U.S.) population and identify factors associated with a high level of thyroid cancer-specific fear that may contribute to overtreatment. Methods: We conducted a cross sectional survey using Prolific Academic®, an online survey platform. The survey was administered in August 2020 to English speaking adults (>17 years) in the U.S. who were registered with Prolific. The target sample was stratified to represent the demographics of the U.S. population. A validated, 8-item breast cancer fear scale was adapted to measure thyroid cancer-specific fear. Multivariate logistic regression identified factors significantly associated with high levels of thyroid cancer-specific fear. Results: Of the 1,136 respondents (94.3% eligibility), 50.4% were female, 74.1% White, and the mean age was 45 years (SD 16 years). Overall, 47.5% of respondents had high levels of thyroid cancer-specific fear. Multivariate regression demonstrated that age <40 years (OR 2.46 vs. 65+ [95%CI 1.60-3.80] ) and female gender (OR 1.48 vs. Male [95%CI 1.13-1.93] ) were associated with high levels of thyroid cancer fear. Believing thyroid cancer (OR 2.71 [95%CI 1.99-3.69] ) and cancer in general are serious (OR 1.53 [95%CI 1.13-2.08] ) were also associated with high levels of thyroid cancer fear. Respondents who overestimated thyroid cancer incidence (OR 1.64 [95%CI 1.25-2.13] ) and believed they had a high chance of developing cancer (OR 1.70 [95%CI 1.19-2.42] ) were also more likely to have high fear of thyroid cancer. Conclusion: Thyroid cancer-specific fear is prevalent in U.S. adults particularly in females and those younger than 40 years. Because disease-specific fear is associated with overtreatment, targeted education about the seriousness, incidence, and risk factors for developing thyroid cancer may decrease public fear and possibly overtreatment related to “scared decision making.”
- 7 December 2023
- Published by SAGE Publications in Thyroid®
- Vol. 33 (12) , 1434-1440
Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal?
Background: The use of thyroid ultrasound increases yearly, adding to costs and overdetection of clinically irrelevant nodules. We investigated which indications most commonly prompt referral for thyroid ultrasound and the diagnostic utility by indication. Methods: We performed a retrospective observational cohort study of adults (≥18 years) undergoing an initial dedicated thyroid ultrasound between 2017 and 2019 at a tertiary academic center. Indicated reasons for referral were categorized into suspected palpable nodule (SPN), compressive symptoms (CS), metabolic symptoms (MS), screening due to high-risk factors, follow-up of incidental finding on other imaging, and combination of factors. Percentage of ultrasounds with an identifiable nodule and with a nodule recommended for biopsy was compared by indication. Separate logistic regression models were used to identify factors associated with finding any nodule and a biopsy-recommended nodule. Results: Among the 1739 patients included, the most common indication for thyroid ultrasound was SPN (40%), followed by incidental imaging (28%), CS (13%), combination (11%), MS (6%), and high-risk factors (2%). Overall, 62% of ultrasounds identified a nodule. Ultrasounds performed for incidental findings had the highest rate of nodule identification (94%), compared with 55%, 39%, and 43%, for SPN, CS, and MS, respectively ( p < 0.05). Only 27% of ultrasounds identified a biopsy-recommended nodule. Nodules found incidentally had the highest rate of biopsy-recommended nodules at 55%. Rates of biopsy-recommended nodules for SPN, CS, and MS were 21%, 6%, and 10%, respectively. Logistic regression demonstrated that compared with patients referred for an SPN, those with incidental nodules were 10 times more likely to have a nodule found on ultrasound (odds ratio [OR] = 10.6 [CI 7.0–16.0]), while those referred for CS were half as likely to have a nodule (OR = 0.5 [CI 0.4–0.7]). Similar factors were associated with identification of biopsy-recommended nodules. Conclusions: Of all new dedicated thyroid ultrasounds, only a quarter find biopsy-recommended nodules, and nearly 40% do not identify a nodule at all. Notably, only 55% of ultrasounds done for SPN found a nodule. Ultrasound for CS and MS had the lowest rates of detecting nodules. Providing clear guidance on when to order thyroid ultrasounds can help reduce unnecessary health care utilization and potential overtreatment.
- 7 December 2023
- Published by SAGE Publications in Thyroid®
- Vol. 33 (12) , 1434-1440
Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal?
Background: The use of thyroid ultrasound increases yearly, adding to costs and overdetection of clinically irrelevant nodules. We investigated which indications most commonly prompt referral for thyroid ultrasound and the diagnostic utility by indication. Methods: We performed a retrospective observational cohort study of adults (≥18 years) undergoing an initial dedicated thyroid ultrasound between 2017 and 2019 at a tertiary academic center. Indicated reasons for referral were categorized into suspected palpable nodule (SPN), compressive symptoms (CS), metabolic symptoms (MS), screening due to high-risk factors, follow-up of incidental finding on other imaging, and combination of factors. Percentage of ultrasounds with an identifiable nodule and with a nodule recommended for biopsy was compared by indication. Separate logistic regression models were used to identify factors associated with finding any nodule and a biopsy-recommended nodule. Results: Among the 1739 patients included, the most common indication for thyroid ultrasound was SPN (40%), followed by incidental imaging (28%), CS (13%), combination (11%), MS (6%), and high-risk factors (2%). Overall, 62% of ultrasounds identified a nodule. Ultrasounds performed for incidental findings had the highest rate of nodule identification (94%), compared with 55%, 39%, and 43%, for SPN, CS, and MS, respectively ( p < 0.05). Only 27% of ultrasounds identified a biopsy-recommended nodule. Nodules found incidentally had the highest rate of biopsy-recommended nodules at 55%. Rates of biopsy-recommended nodules for SPN, CS, and MS were 21%, 6%, and 10%, respectively. Logistic regression demonstrated that compared with patients referred for an SPN, those with incidental nodules were 10 times more likely to have a nodule found on ultrasound (odds ratio [OR] = 10.6 [CI 7.0–16.0]), while those referred for CS were half as likely to have a nodule (OR = 0.5 [CI 0.4–0.7]). Similar factors were associated with identification of biopsy-recommended nodules. Conclusions: Of all new dedicated thyroid ultrasounds, only a quarter find biopsy-recommended nodules, and nearly 40% do not identify a nodule at all. Notably, only 55% of ultrasounds done for SPN found a nodule. Ultrasound for CS and MS had the lowest rates of detecting nodules. Providing clear guidance on when to order thyroid ultrasounds can help reduce unnecessary health care utilization and potential overtreatment.